Clinical Trial Update: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 study investigating SHR0302 for moderately to severely active ulcerative colitis; results and safety data are not yet disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Ulcerative Colitis | Phase 3 | Status: UNKNOWN